golgin 97 Activators
Golgin 97 activators form a diverse group of chemicals that intricately modulate the function and dynamics of the golgin 97 protein, a key player in cellular processes related to Golgi organization and vesicular trafficking. This group includes Brefeldin A, Golgicide A, Monensin, Exo1, GCA, Salinomycin, NSC23766, Golgicide B, Retro-2, and ARF Inhibitor 1, each playing a pivotal role in influencing golgin 97-mediated cellular processes. These activators exert their effects through indirect mechanisms, disrupting various cellular pathways and processes that ultimately lead to alterations in golgin 97 dynamics and localization. For example, Brefeldin A and Golgicide A interfere with the interaction between golgin 97 and the small GTPase Arl1. This disruption results in Golgi stress responses and changes in golgin 97 activity, highlighting the intricate nature of golgin 97 regulation within the cellular environment.
Monensin and Salinomycin, among other activators, impact Golgi function by disrupting ion homeostasis. This disruption not only affects Golgi organization but also influences golgin 97 dynamics, showcasing the interconnectedness of cellular processes. The wide range of mechanisms through which these activators operate collectively underscores the complexity of golgin 97 regulation and its indispensable role in cellular processes associated with Golgi organization and vesicular trafficking. Understanding the targeted modulation of golgin 97 by these diverse activators provides valuable insights into potential avenues for studying and comprehending cellular processes that rely on precise Golgi dynamics. The intricate interplay between golgin 97 and the diverse pathways influenced by these chemicals highlights the versatility of approaches in modulating Golgi-related processes. This knowledge not only expands our understanding of golgin 97 function but also opens up possibilities for targeted interventions in cellular processes reliant on Golgi dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a golgin 97 activator that acts indirectly by disrupting ion homeostasis, particularly sodium and potassium gradients across cellular membranes. The altered ion concentrations impact Golgi function, leading to changes in golgin 97 dynamics and localization. This indirect activation influences cellular processes related to Golgi organization and vesicular trafficking mediated by golgin 97. | ||||||
Exo1 | 461681-88-9 | sc-200752 sc-200752A | 10 mg 50 mg | $84.00 $297.00 | 4 | |
Exo1 is a golgin 97 activator that acts indirectly by promoting Golgi fragmentation. By inhibiting the Exo84 subunit of the exocyst complex, Exo1 disrupts vesicle tethering and fusion at the Golgi, influencing golgin 97 localization and activity. This indirect activation affects cellular processes dependent on golgin 97-mediated Golgi organization and vesicular trafficking. | ||||||
Glycocholic acid | 475-31-0 | sc-218574 sc-218574A sc-218574B sc-218574C sc-218574D sc-218574E | 100 mg 1 g 5 g 10 g 50 g 100 g | $73.00 $188.00 $680.00 $1259.00 $1675.00 $3131.00 | 4 | |
Glycocholic acid is a golgin 97 activator that acts indirectly by disrupting Golgi structure and function. Glycocholic acid inhibits the interaction between golgin 97 and Arl1, leading to altered Golgi dynamics and golgin 97 localization. This indirect activation influences cellular processes related to Golgi organization and vesicular trafficking mediated by golgin 97. | ||||||
Salinomycin | 53003-10-4 | sc-253530 sc-253530C sc-253530A sc-253530B | 5 mg 10 mg 25 mg 100 mg | $162.00 $241.00 $406.00 $474.00 | 1 | |
Salinomycin is a golgin 97 activator that acts indirectly by disrupting ion homeostasis, particularly potassium gradients. The altered ion concentrations impact Golgi function, leading to changes in golgin 97 dynamics and localization. This indirect activation influences cellular processes related to Golgi organization and vesicular trafficking mediated by golgin 97. | ||||||
Wnt Synergist, QS11 | 944328-88-5 | sc-222417 sc-222417A | 5 mg 25 mg | $141.00 $607.00 | ||
Wnt Synergist, QS11 is a golgin 97 activator that acts indirectly by inhibiting the ARF GTPase. By disrupting ARF-mediated vesicle formation, this compound influences Golgi structure, leading to changes in golgin 97 dynamics and localization. This indirect activation affects cellular processes dependent on golgin 97-mediated Golgi organization and vesicular trafficking. | ||||||